Influence ofglyceryl trinitrate and nifedipine on global myocardial metabolism Patients and methods Twenty two patients scheduled for elective coronary artery operation gave their informed consent to participate in this study, which had the approval of the local medical ethical committee. Patients with left ventricular end diastolic pressure > 15 mmHg, ejection fraction < 50%, atrioventricular conduction defects, or unstable angina pectoris were excluded from the study. Those undergoing additional operation (for example valve replacement or aneurysmectomy) were also excluded. All patients were taking # adrenergic blocking drugs before operation. Except for nitrates, oral medication was discontinued the evening before operation. Patients were randomly allocated to one of two groups. One group of 11 patients received glyceryl trinitrate at an initial rate of 3 pg/kg/min and another group of 11 patients received nifedipine at an initial rate of 0.7 pg/kg/min. All infusions were given via a syringe pump through polypropylene syringes and infusion lines. Black syringes and lines were used for nifedipine because it undergoes rapid decomposition in light.
Patients were premedicated with oral lorazepam (4-5 mg) two hours before operation. In the operating room two peripheral infusions and an 18 gauge radial artery cannula were inserted under local analgesia. A triple lumen thermodilution pulmonary artery catheter and a Wilton Webster coronary sinus catheter (type CCS-7U 90B) were introduced via the left subclavian vein. The Wilton Webster catheter was advanced into the coronary sinus so that the external thermistor lay 1-1 5cm from the ostium. We used image intensification fluoroscopy and injection of contrast medium for guidance.
Pancuronium bromide (2 mg) was given after preoxygenation, then fentanyl (100 p g/kg) was injected over 3 min. When the patient became unresponsive to commands additional pancuronium bromide (6 mg) was given and ventilation was assisted and then controlled manually. Table 1 shows details of the patients. The two groups were comparable with respect to age, weight, and degree of coronary artery disease. Table 2 shows details of infusion rates and total dose requirements of glyceryl trinitrate and nifedipine.
HAEMODYNAMIC FUNCTION In the present study three patients in group 1 also failed to respond to glyceryl trinitrate after sternotomy. In these patients it proved impossible to control post-sternotomy hypertension despite very high doses (up to 25 mg/min). Blood pressure could only be controlled by the administration of ,B adrenergic blocking drugs (practolol 2 intravenous doses of 5 mg) and the addition of isoflurane to the air and oxygen gas mixture.
The calcium antagonist nifedipine is a potent vasodilator of peripheral and coronary arteries. It reduces myocardial oxygen demand by decreasing left ventricular afterload.18 In conscious patients intravenous nifedipine given during cardiac catheterisation produced transient increases in coronary sinus blood flow without significant reduction of MVO2.5 When propranolol was given before nifedipine, however, there was a significant and sustained reduction of MVO2.6 Intracoronary administration of nifedipine before percutaneous transluminal coronary angioplasty reduced myocardial lactate production during angioplasty. 9 In our study the patients given nifedipine remained haemodynamically stable. In view of the known vasodilating action of nifedipine on the coronary arteries it was not surprising to find an increase in coronary sinus blood flow and a corresponding decrease in coronary vascular resistance. The pronounced increase in MVO2 in this group was unexpected, however, since there were no significant changes in left or right ventricular workload. The 250% increases in heart rate (found in both groups) can only be at the most a partial explanation for the observed increase in MVO2. In four patients given nifedipine, heart rate changed by < 10% after sternotomy, yet coronary sinus blood flow and MVO2 increased by 56% and 52% respectively. There is evidence from animal studies that calcium channel blocking agents interfere with catecholamine release and storage in nerve cells and myocardium.Y Myocardial release of noradrenaline after oral administration of both verapamil and nifedipine has been reported in man.21 22 An effect on MVO2 was not reported in these studies. Because we did not measure catecholamines we do not know whether myocardial catecholamine release played a role in the apparently paradoxical increase in MVO2 in our patients. At the moment we have no satisfactory explanation for the increase in MVO2 found in this study, which clinically did not appear to be accompanied by any detrimental effect on myocardial function. The patients in our study all had stable angina pectoris and unimpaired left ventricular function before operation. In this group of patients nifedipine proved to be more effective than glyceryl trinitrate for the control of intraoperative blood pressure. Because of the potentially cardiodepressant effect of nifedipine, however, we cannot recommend its use in patients with impaired myocardial function. Our finding that nifedipine significantly increased myocardial oxygen consumption suggests that caution needs to be exercised in the use of this agent in patients with unstable angina pectoris undergoing coronary artery operation. An additional disadvantage is that compared with glyceryl trinitrate and nitroprusside, which are rapidly metabolised, nifedipine has a relatively long duration of action and thus its effect cannot readily be reversed.
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